Effect of Highly Active Antiretroviral Therapy on Tacrolimus Pharmacokinetics in Hepatitis C Virus and HIV Co-Infected Liver Transplant Recipients in the ANRS HC-08 Study

Author： Teicher Elina  

Publisher： Adis International

ISSN： 0312-5963

Source： Clinical Pharmacokinetics, Vol.46, Iss.11, 2007-01, pp. : 941-952

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Therapy of Chronic Hepatitis C Virus Infection in HIV Co-Infected People

By  

Current Pharmaceutical Design, Vol. 10, Iss. 17, 2004-07 ,pp. : 2111-2122

Bentham Science Publishers

Access to resources Recommend Favorite

Lopinavir/Ritonavir Pharmacokinetics in HIV and Hepatitis C Virus Co-Infected Patients without Liver Function Impairment: Influence of Liver Fibrosis

By Moltó José   Valle Marta   Blanco Asunción  

Clinical Pharmacokinetics, Vol. 46, Iss. 1, 2007-01 ,pp. : 85-92

Adis International

Access to resources Recommend Favorite

High Variability of Indinavir and Nelfinavir Pharmacokinetics in HIV-Infected Patients with a Sustained Virological Response on Highly Active Antiretroviral Therapy

By Goujard Cécile  

Clinical Pharmacokinetics, Vol. 44, Iss. 12, 2005-01 ,pp. : 1267-1278

Adis International

Access to resources Recommend Favorite

Highly Active Antiretroviral Therapy and Cardiovascular Complications in HIV-Infected Patients

By  

Current Pharmaceutical Design, Vol. 9, Iss. 18, 2003-07 ,pp. : 1475-1481

Bentham Science Publishers

Access to resources Recommend Favorite

Liver transplant recipients with hepatitis C virus (HCV) infections require lower doses of tacrolimus than those without HCV infections

By  

Inpharma, Vol. 1, Iss. 1502, 2005-01 ,pp. : 19-19

Adis International

Access to resources Recommend Favorite